Overview

Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA)

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of diclofenac DDEA 2.32 % in patient suffering from knee osteoarthritis (OA).
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Diclofenac